From an October AFR article: "QScan owns more than 70 clinics and makes about $70 million a year at the EBITDA line. Bidders were told to expect more than 10 per cent annual growth through the forecast period."
Someone has previously mentioned D&A would be decent in this business. EBIT @ 10x = well below $700m being contemplated.
Consider how much Quadrant has invested into QScan + bolt-ons + its return requirements and you can determine whether they're talking EBITDA or EBIT in the press.
It is rare to see EBIT numbers without being explicitly disclosed by the reporter (in my humble opinion).
From an October AFR article: "QScan owns more than 70 clinics...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IFT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.72 |
Change
-0.130(1.32%) |
Mkt cap ! $9.394B | |||
| Open | High | Low | Value | Volume |
| $9.90 | $9.90 | $9.71 | $1.572M | 160.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 154 | $9.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.77 | 508 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IFT (ASX) Chart |